These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 30702051
1. Immunization with adult Schistosoma mansoni tegument, treated with sub-curative praziquantel, partially protects mice against the infection. El-Aswad BEW, Harba NM, Moharm IM, Mahmoud SF. J Helminthol; 2019 Jan 31; 94():e26. PubMed ID: 30702051 [Abstract] [Full Text] [Related]
2. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, de Melo AL, Caliari MV, Almeida GT, Venancio TM, Verjovski-Almeida S, Oliveira SC. PLoS Negl Trop Dis; 2008 Oct 01; 2(10):e308. PubMed ID: 18827884 [Abstract] [Full Text] [Related]
3. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production. Rezende CM, Silva MR, Santos IG, Silva GA, Gomes DA, Goes AM. Immunol Lett; 2011 Dec 30; 141(1):123-33. PubMed ID: 21945176 [Abstract] [Full Text] [Related]
4. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection. Martins VP, Pinheiro CS, Figueiredo BC, Assis NR, Morais SB, Caliari MV, Azevedo V, Castro-Borges W, Wilson RA, Oliveira SC. Clin Dev Immunol; 2012 Dec 30; 2012():962538. PubMed ID: 22927873 [Abstract] [Full Text] [Related]
5. Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice. Morais SB, Figueiredo BC, Assis NRG, Homan J, Mambelli FS, Bicalho RM, Souza C, Martins VP, Pinheiro CS, Oliveira SC. Front Immunol; 2018 Dec 30; 9():1762. PubMed ID: 30105029 [Abstract] [Full Text] [Related]
11. Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment. Chalmers IW, Fitzsimmons CM, Brown M, Pierrot C, Jones FM, Wawrzyniak JM, Fernandez-Fuentes N, Tukahebwa EM, Dunne DW, Khalife J, Hoffmann KF. PLoS Negl Trop Dis; 2015 Dec 30; 9(7):e0003920. PubMed ID: 26147973 [Abstract] [Full Text] [Related]
12. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection. Gonçalves de Assis NR, Batistoni de Morais S, Figueiredo BC, Ricci ND, de Almeida LA, da Silva Pinheiro C, Martins Vde P, Oliveira SC. PLoS One; 2015 Dec 30; 10(5):e0125075. PubMed ID: 25942636 [Abstract] [Full Text] [Related]
13. Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid. Riner DK, Ndombi EM, Carter JM, Omondi A, Kittur N, Kavere E, Korir HK, Flaherty B, Karanja D, Colley DG. PLoS Negl Trop Dis; 2016 Dec 30; 10(12):e0005180. PubMed ID: 27926921 [Abstract] [Full Text] [Related]
15. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens. Brindley PJ, Strand M, Norden AP, Sher A. Mol Biochem Parasitol; 1989 May 01; 34(2):99-108. PubMed ID: 2496307 [Abstract] [Full Text] [Related]
16. Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection. Araujo JM, de Melo TT, de Sena IC, Alves CC, Araujo N, Durães Fdo V, Oliveira SC, Fonseca CT. Acta Trop; 2012 Nov 01; 124(2):140-6. PubMed ID: 22842304 [Abstract] [Full Text] [Related]